BRCA2 MUTATION CARRIER
Clinical trials for BRCA2 MUTATION CARRIER explained in plain language.
Never miss a new study
Get alerted when new BRCA2 MUTATION CARRIER trials appear
Sign up with your email to follow new studies for BRCA2 MUTATION CARRIER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Tough-to-Treat cancers
Disease control OngoingThis study tests two drug combinations (olaparib plus either vistusertib or capivasertib) in people with recurrent endometrial, triple-negative breast, ovarian, or related cancers. The goal is to find the safest dose and see if the drugs can control tumor growth. About 159 partic…
Matched conditions: BRCA2 MUTATION CARRIER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Diabetes drug metformin tested as breast cancer shield
Prevention OngoingThis study tests whether the diabetes drug metformin can prevent breast cancer in women at high risk. 86 premenopausal women with atypical breast changes or genetic risk took metformin or a placebo for 12 months. Researchers checked breast tissue samples for abnormal cells to see…
Matched conditions: BRCA2 MUTATION CARRIER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 15, 2026 19:04 UTC